The purpose of the present study was to evaluate the anatomical relationship between 2 the tumor, portal veins, hepatic arteries, and hilar hepatic ducts at the hepatic hilum 3 using a novel preoperative fusion analysis for patients with hilar cholangiocarcinoma. 4 This involved combining 3-dimensional multidetector-row computed tomography 5 (3D-MDCT) with 3-D magnetic resonance imaging (MRI). This novel fusion imaging 6 technique can play an important clinical role for patients undergoing surgery for hilar 7 cholangiocarcinoma. 8 9 Key words: 10 hilar cholangiocarcinoma, 3-dimensional imaging, fusion imaging, MDCT, MRI 11 12
Introduction 1
To determine the optimal surgical procedure for patients with hilar 2 cholangiocarcinoma, it is essential to know the anatomical relationship between the 3 tumor and the vessels around the hepatic hilum in individual patients. Several 4 institutions have recently developed 3-dimensional multidetector-row computed 5 tomography (3D-MDCT) cholangiography or drip infusion 3D-MDCT for use with 6 patients with hilar cholangiocarcinoma [1] [2] [3] [4] . However, it has been said that these 7 radiological examinations have several problems with side effects such as cholangitis or 8 anaphylactic shock due to infusion of the contrast material into the vein or bile duct. 9 Therefore, we were looking forward to a new modality and method. To our knowledge 10 there have been no published reports concerning the preoperative visualization of 11 3D-MDCT fusion images combined with 3D-magnetic resonance 12 cholangiopancreatography (MRCP) images. The purpose of the present study was to 13 preoperatively evaluate portal veins and hilar hepatic ducts at the hepatic hilum in 14 patients with hilar cholangiocarcinoma. The patient was a 52-year-old man. He consulted the Tsukuba University Hospital 18 complaining of jaundice. Laboratory blood samples showed elevated total bilirubin and 19 carcinogenic antigen (CA) 19-9, and MDCT and MRI were subsequently performed 20 ( Fig. 1) . 21 MDCT images were acquired using an IDT-16 imager (Philips, Eindhoven, The 22 Netherlands). Scan settings included a pitch of 17, a 0.75-second scan time per rotation, 23 a table speed of 12 mm/rotation, and a detector configuration of 0.75×16 mm. A power 24 injector was used to administer 100 mL iopamidol (370 mgI/mL) at 4 mL/s through a 25 20-G high pressure intravenous catheter. The MDCT protocol obtained 3 sets of hepatic 26 images in succession, including images of arterial, and those of portal venous, and 27 hepatic venous phases. The arterial phase images were obtained 5 seconds after peak 28 aortic enhancement, portal venous phase images were taken 70 seconds after starting the 29 injection, and the hepatic venous phase began 180 seconds after starting the injection.
30
The MRI was performed on a 1.5 Tesla MRI imager (Achieva Nova Dual, Philips
31
Medical Systems, Eindhoven, The Netherlands) 32 The preoperative fusion examination consisted of 4 steps. We first combined heavily 33 T2-weighted MRCP images with axial thin slice 3D-T1-turbo field echo (TFE) images. during the experiratory phase is one of the most important aspects of this method.
10
Obtaining satisfactory images will be easiest with patients who are able to cooperate in 11 this aspect. Third, this study involved only one patient, and our results will therefore 12 need to be confirmed with larger populations.
13
In conclusion, this novel fusion imaging technique should play an important role in 14 preoperative planning for patients undergoing surgery for hilar cholangiocarcinoma. were dilated, and that the confluence of the right and left hepatic ducts is tapered and 5 obstructed at the hepatic hilum. 
